Comprehensive medication management is a clinical service in which every medication a patient takes is assessed individually for appropriateness, effectiveness, safety given their other conditions and drugs, and whether the patient can actually take it as intended. It covers prescriptions, over-the-counter products, supplements, and inhalers, and it continues through follow-up until the problems found are resolved.
The defining word is comprehensive. A review that looks only at the drugs one prescriber wrote, or only at the medications relevant to a single condition, is a narrower service. Comprehensive medication management starts from everything the patient is actually taking, which is usually not the same as the list in any one chart.
It is delivered by a pharmacist working as part of the care team rather than in parallel with it, which is what allows a finding to become a change. A review that produces a report nobody acts on has not delivered the service.
Medication therapy management is a Medicare Part D program requirement, administered by drug plans, whose core deliverable is an annual comprehensive medication review for beneficiaries who meet targeting criteria. Comprehensive medication management is a standard of clinical practice, not a benefit category. The two overlap in activity and differ in scope, integration, and who is accountable for the outcome.
The terms are used interchangeably across the industry and they should not be. Three differences do real work:
Medication therapy management is offered by the Part D plan to beneficiaries the plan has identified. Comprehensive medication management is initiated within the practice as part of the patient's care, and the pharmacist is accountable to the care team for what happens next.
Medication therapy management, as implemented, often centers on the annual review and targeted interventions. Comprehensive medication management evaluates all medications against all active conditions, and treats the medication list itself as something to be corrected rather than documented.
This is the sharpest difference. Comprehensive medication management is not complete when the assessment is written. It continues through implementation and monitoring until the identified problems are resolved or deliberately accepted. A single annual encounter, however thorough, is a review rather than management.
The practical consequence for a practice is that the two answer different questions. Medication therapy management answers whether a plan met an obligation to a member. Comprehensive medication management answers whether this patient's regimen is right today, and it stays open until it is.
A licensed pharmacist, in almost all implementations, working with the prescribing team. What that pharmacist is permitted to change without a new order depends entirely on state law and on whether a collaborative practice agreement is in place, and this varies more between states than most national vendors acknowledge.
Under a collaborative practice agreement, a pharmacist may be authorized to initiate, modify, or discontinue therapy within a defined protocol, order relevant laboratory monitoring, and manage titration directly. Without one, the same pharmacist can assess and recommend, and every change waits on a prescriber. Both models deliver the service; they differ substantially in how quickly a finding becomes a change, and therefore in how much clinician time the program consumes.
Clinical staff may support the work, gathering the medication history, confirming what the patient is actually taking against what was prescribed, and following up on adherence. The clinical judgment about whether a regimen is appropriate belongs to the pharmacist.
There is no single CPT code for comprehensive medication management, and any vendor who tells you otherwise is describing something narrower. It is most often reimbursed through one of three routes: the pharmacist medication management codes, time captured under an existing care management program, or a value-based arrangement that pays for the outcome rather than the encounter.
CPT 99605, 99606, and 99607 describe medication therapy management services furnished by a pharmacist face-to-face with the patient, in 15-minute increments, with 99605 for a new patient, 99606 for an established one, and 99607 for each additional 15 minutes. Coverage for these codes under Medicare Part B is limited, and commercial and Medicaid coverage varies by payer and by state.
Medication reconciliation and management are already required elements of several care management programs. In transitional care management, medication reconciliation must be completed on or before the face-to-face visit. In chronic care management, medication work performed by clinical staff counts toward the monthly time threshold. This is the most common route in practice, and it requires that the time be attributed correctly and not counted twice.
Where a practice or group carries risk, comprehensive medication management is funded by what it prevents rather than by an encounter code. This is the cleanest economic fit for the service and the hardest to start from a standing position.
Medications are one of the few levers a practice controls directly between visits. In a risk-bearing arrangement, the service is funded by avoided utilization and by quality measures that depend on medication use, which means it is judged on regimen changes made and problems resolved rather than on reviews completed.
That changes what a program should measure. Reviews completed is an activity count and it will look healthy while nothing improves. The measures that track the contract are medication-related problems identified and resolved, regimen simplifications that survive to the next fill, and adherence sustained past the first refill rather than at the moment of the call.
It also changes who should be prioritized. A panel-wide annual review distributes effort evenly across a population whose risk is not evenly distributed. Prioritizing by regimen complexity, recent transitions of care, and known adherence gaps concentrates pharmacist time where a change is most likely to prevent something.
No. Medication therapy management is a Medicare Part D program requirement administered by drug plans, built around an annual comprehensive medication review for targeted beneficiaries. Comprehensive medication management is a standard of clinical practice, initiated in the care team, covering all medications against all conditions, and continuing through follow-up until problems are resolved.
In practice, yes. The assessment is a pharmacist's clinical judgment about appropriateness, effectiveness, safety, and adherence across a full regimen. Clinical staff can gather the history and support follow-up, but the evaluation itself is pharmacist work.
Only where state law allows it and a collaborative practice agreement authorizes it. Under such an agreement a pharmacist may initiate, adjust, or stop therapy within a defined protocol. Without one, the pharmacist recommends and the prescriber acts. Authority varies substantially by state.
Not a single dedicated one. CPT 99605, 99606 and 99607 cover pharmacist-delivered medication therapy management in 15-minute increments, and Part B coverage for them is limited. Most programs are funded through time captured under an existing care management program or through a value-based arrangement.
Reconciliation establishes an accurate list, usually at a transition. Comprehensive medication management starts where reconciliation ends: it evaluates whether each medication on that accurate list should be there, at that dose, given everything else, and then follows the changes through.
Yes, when clinical staff perform it under the billing practitioner's direction and it meets the program's requirements. The constraint is that the same minutes cannot also be counted toward another service, which requires time to be recorded by activity as the work happens rather than totaled at month end.
Patients on complex regimens, patients recently discharged from an inpatient stay, patients seeing several prescribers who do not share a chart, and patients with a known adherence gap. Prioritizing by these factors concentrates pharmacist time where a change is most likely to prevent an event.
The pharmacist medication management CPT codes describe face-to-face services. The broader practice of comprehensive medication management is routinely delivered by telephone or video within a care management program, where the reimbursement route does not carry a face-to-face requirement.
Four things distinguish a clinical service from a review exercise. Whether a licensed pharmacist makes the clinical assessment rather than a technician completing a checklist. Whether the pharmacist has authority to act on findings, through a collaborative practice agreement or an equivalent arrangement, or can only recommend and wait. Whether the service continues to follow-up and resolution rather than ending at the review. And whether findings reach the prescriber in a usable form, with the clinical context attached, rather than as a queue of messages.
Code descriptors on this page reflect the AMA CPT code set current as of CY2026; CPT is revised annually and payer coverage varies. Scope-of-practice and collaborative practice authority are set by state law. This page describes the service and is not billing advice for a specific claim.
If managing medications feels overwhelming, or if you're concerned about the impact of your medications on your health, it's time to explore how Clinical Pharmacy services can support you. Talk to your healthcare provider about incorporating clinical pharmacy services into your care team. Together, we can ensure your medications are working for you, not against you, as part of your journey toward optimal health.
Contact us